DiscoverCNS[podcast] Multi-disease, point-of-care and decentralised molecular testing should be the norm, says Sriram Natarajan
[podcast] Multi-disease, point-of-care and decentralised molecular testing should be the norm, says Sriram Natarajan

[podcast] Multi-disease, point-of-care and decentralised molecular testing should be the norm, says Sriram Natarajan

Update: 2023-09-08
Share

Description

<iframe allowfullscreen="" frameborder="0" height="30" mozallowfullscreen="true" src="https://archive.org/embed/my-movie-podcast" webkitallowfullscreen="true" width="470"></iframe>
This podcast features Sriram Natarajan, cofounder and Chief Executive Officer of Molbio Diagnostics - who leads the team behind Truenat - the only World Health Organization (WHO) approved and recommended point-of-care and decentralised molecular test for TB globally. Timely and correct diagnosis helps to avert untimely deaths, and reduce human suffering, says Sriram Natarajan. For infectious diseases, timely and correct diagnosis helps break the chain of infection transmission. Diagnosis remains the key entry point to treatment and care pathway, and towards disease elimination.

Listen to this podcast on Apple Podcasts, Amazon Music, Google Podcasts, Spotify, TuneIn, Podtail, BluBrry, Himalaya, ListenNotes, American Podcasts, CastBox FM, Ivy FM, Player FM, and other podcast streaming platforms.
Thanks

CNS team
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

[podcast] Multi-disease, point-of-care and decentralised molecular testing should be the norm, says Sriram Natarajan

[podcast] Multi-disease, point-of-care and decentralised molecular testing should be the norm, says Sriram Natarajan

CNS www.citizen-news.org